Surgery Book

http://www.fpnotebook.com/

Ketamine

Aka: Ketamine, Ketalar
Advertisement
  1. Mechanism
    1. Derived from Phencyclidine (PCP)
    2. Dissociative anesthetic with Analgesic effect
    3. Anesthesia with rare respiratory depression
  2. Dose: Sedation
    1. Intravenous: 1-2 mg/kg IV
    2. Intramuscular: 2-4 mg/kg IM
    3. Consider concurrent Midazolam (especially in adults)
      1. Blunts Sympathomimetic effect
      2. Reduces agitation on recovery from Ketamine
      3. Versed dosing: 0.05 to 0.1 mg/kg IV (MAX 4.0 mg)
  3. Pharmacokinetics
    1. Intravenous dosing
      1. Onset: 1 minutes
      2. Duration: 10-20 minutes
    2. Intramuscular dosing
      1. Onset: 5 minutes
      2. Duration: 15-45 minutes
  4. Indications
    1. Drug of choice for Conscious Sedation in children
      1. Not FDA approved
      2. Ear Foreign Body
      3. Entrapment of penis in zipper
      4. Abscess Incision and Drainage
      5. Imaging studies
      6. Laceration Repair or Wound Debridement
      7. Fracture or dislocation reduction
    2. Sedation in Rapid Sequence Intubation
      1. Useful in Status Asthmaticus (Bronchodilator)
  5. Contraindications
    1. Increased Intracranial Pressure
      1. Use Fentanyl with Midazolam if ICP is of concern
    2. Coronary Artery Disease
    3. Ketamine hypersensitivity
  6. Efficacy and Safety
    1. Results in >90% of children with adequate Sedation
  7. Pregnancy
    1. Pregnancy Category C
  8. Adverse Effects
    1. Blood Pressure elevation
      1. Consider concurrent Midazolam in adults
    2. Confusion or Delirium
    3. Anterograde amnesia
    4. Visual hallucinations
      1. Floating outside the body
      2. Dream-like state
    5. Flashbacks may occur weeks after use
    6. Agitation on recovery from agent
      1. Consider concurrent Midazolam in adults
    7. Transient laryngospasm (occurs in 0.4% of cases)
    8. Ptyalism
      1. Treat with anticholinergics (e.g. Diphenhydramine)
    9. Respiratory depression
      1. Brief Positive Pressure Ventilation may be needed
      2. Mild Oxygen desaturation (most common side effect)
        1. Most cases: Return to baseline within 2 minutes
  9. Adverse Effects
    1. Significant oxygen desaturation <85% occurred in <1%
  10. Illicit use
    1. Club Drug
    2. Date Rape Drug used for Sedation
    3. Use
      1. Smoked as powder with Tobacco or Marijuana
      2. Inhaled intranasally
    4. Illicit use is often in combination with other agents
      1. Methamphetamine
      2. Cocaine
      3. Sildenafil
      4. Heroin
  11. Street Names when used illicitly
    1. Special K
    2. Super K
    3. Kit-Kat
    4. Keets
    5. Super acid
    6. Jet
    7. Cat Valiums
    8. Vitamin K
  12. Toxicology: Detection of illicit use
    1. Specific tests to detect Ketamine usually not available
    2. Ketamine will cause positive PCP on Urine Tox Screen
  13. References
    1. Brown (2005) Am Fam Physician 71:85-90
    2. Gahlinger (2004) Am Fam Physician 69:2619-27
    3. Green (1998) Ann Emerg Med 31:688-97
    4. Jansen (1993) BMJ 306:601-2
    5. Parker (1997) Pediatrics 99:427-31
Medication Costs
Ketamine HCl (on 2/9/2012 at DrugStore.com)
Ketamine HCl 50mg/ml Solution #10 for $17.70 ($1.77/unit)
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Ketalar (C0022613)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D007649
English ketalar, Ketalar
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Ketamine (C0022614)

Definition (NCI) A cyclohexanone derivative with analgesic and anesthetic properties. Although its mechanism of action is not well understood, ketamine appears exerts complex pharmacological actions including inhibition of biogenic amine uptake, binding to opioid receptors, and inhibition of N-methyl D-aspartate (NMDA) receptors. Because of the involvement of spinal NMDA receptors in the process of central sensitization, this agent may reduce pain perception and induce sedation.
Definition (CHV) a kind of anesthetic drug
Definition (NCI) A drug used to cause a loss of feeling and awareness and to induce sleep in patients having surgery. It is also being studied in the treatment of nerve pain caused by chemotherapy. Ketamine blocks pathways to the brain that are involved in sensing pain. It is a type of general anesthetic.
Definition (MSH) A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
Definition (CSP) rapid-acting general anesthetic, animal anesthetic, and emerging drug of abuse.
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D007649
SnomedCT 31706007, 333847008, 373464007
English ketamine, Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)-, Ketamine [Chemical/Ingredient], 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone, Ketamine (product), Ketamine (substance), Ketamine, KETAMINE
Swedish Ketamin
Czech ketamin
Finnish Ketamiini
Italian 2-(2-clorofenil)-2-(metilamino) cicloesanone, Chetamina
Russian KETAMIN, CI-581, КЕТАМИН
Japanese ケタミン
Croatian KETAMIN
Spanish Quetamina, Ketamina, Cetamina, cetamina, ketamina (producto), ketamina (sustancia), ketamina
Portuguese Quetamina, Cetamina, Ketamina
Polish Ketamina
French Kétamine
German Ketamin
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree